What’s the Future of Science Twitter?

In the wake of Elon Musk’s takeover, many researchers are exploring their options with the open-source platform Mastodon.

Written byKatherine Irving
| 2 min read
An iPhone screen with the app icons for Twitter and Mastodon side by side. Other apps are arranged in rows around them.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Two weeks after Elon Musk’s takeover of Twitter, many people who’ve used the platform to participate in conversations around science and academia have publicly contemplated setting off for new social media territories. But many are unsure where to go, and when.

Even prior to the takeover, scientists had voiced concerns about the spread of misinformation and hate speech on the platform, Science reports. Musk himself has previously tweeted information about the pandemic and health science that experts have deemed dangerous and false, Forbes reports. Then, on November 4, Musk-initiated firings dissolved Twitter’s curation team, which had aimed to tamp down the dissemination of misinformation, Science reports. Musk also began implementing rapid changes to Twitter’s so-called blue check program, including allowing users to buy the badges once exclusive to verified accounts of note. The chaos that ensued, including a flurry of fake brand and celebrity accounts, has further undermined trust in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Katherine Irving

    Katherine Irving is an intern at The Scientist. She studied creative writing, biology, and geology at Macalester College, where she honed her skills in journalism and podcast production and conducted research on dinosaur bones in Montana. Her work has previously been featured in Science.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies